Paper-Based Biosensors: Frontiers in Point-of-Care Detection of COVID-19 Disease

This review summarizes the state of the art of paper-based biosensors (PBBs) for coronavirus disease 2019 (COVID-19) detection. Three categories of PBB are currently being been used for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) diagnostics, namely for viral gene, viral antigen and...

Descripción completa

Detalles Bibliográficos
Autor principal: Antiochia, Riccarda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8067807/
https://www.ncbi.nlm.nih.gov/pubmed/33917183
http://dx.doi.org/10.3390/bios11040110
_version_ 1783682889134637056
author Antiochia, Riccarda
author_facet Antiochia, Riccarda
author_sort Antiochia, Riccarda
collection PubMed
description This review summarizes the state of the art of paper-based biosensors (PBBs) for coronavirus disease 2019 (COVID-19) detection. Three categories of PBB are currently being been used for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) diagnostics, namely for viral gene, viral antigen and antibody detection. The characteristics, the analytical performance, the advantages and drawbacks of each type of biosensor are highlighted and compared with traditional methods. It is hoped that this review will be useful for scientists for the development of novel PBB platforms with enhanced performance for helping to contain the COVID-19 outbreak, by allowing early diagnosis at the point of care (POC).
format Online
Article
Text
id pubmed-8067807
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-80678072021-04-25 Paper-Based Biosensors: Frontiers in Point-of-Care Detection of COVID-19 Disease Antiochia, Riccarda Biosensors (Basel) Review This review summarizes the state of the art of paper-based biosensors (PBBs) for coronavirus disease 2019 (COVID-19) detection. Three categories of PBB are currently being been used for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) diagnostics, namely for viral gene, viral antigen and antibody detection. The characteristics, the analytical performance, the advantages and drawbacks of each type of biosensor are highlighted and compared with traditional methods. It is hoped that this review will be useful for scientists for the development of novel PBB platforms with enhanced performance for helping to contain the COVID-19 outbreak, by allowing early diagnosis at the point of care (POC). MDPI 2021-04-07 /pmc/articles/PMC8067807/ /pubmed/33917183 http://dx.doi.org/10.3390/bios11040110 Text en © 2021 by the author. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Antiochia, Riccarda
Paper-Based Biosensors: Frontiers in Point-of-Care Detection of COVID-19 Disease
title Paper-Based Biosensors: Frontiers in Point-of-Care Detection of COVID-19 Disease
title_full Paper-Based Biosensors: Frontiers in Point-of-Care Detection of COVID-19 Disease
title_fullStr Paper-Based Biosensors: Frontiers in Point-of-Care Detection of COVID-19 Disease
title_full_unstemmed Paper-Based Biosensors: Frontiers in Point-of-Care Detection of COVID-19 Disease
title_short Paper-Based Biosensors: Frontiers in Point-of-Care Detection of COVID-19 Disease
title_sort paper-based biosensors: frontiers in point-of-care detection of covid-19 disease
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8067807/
https://www.ncbi.nlm.nih.gov/pubmed/33917183
http://dx.doi.org/10.3390/bios11040110
work_keys_str_mv AT antiochiariccarda paperbasedbiosensorsfrontiersinpointofcaredetectionofcovid19disease

Ejemplares similares